aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Sano Informed Prescribing, Inc. was founded with the mission to revolutionize personal and population health management by providing fast and clinically precise detection of medications in patients. Their core vision is to enhance medication therapy and improve healthcare outcomes. Sano offers advanced health management tools that enable accurate monitoring of medication adherence and effectiveness, targeting both individual patients and broader populations within the healthcare market.
Notable affiliated individuals include experts in healthcare technology and pharmacology, although specific names are not provided. The company has attracted significant interest from investors focused on innovative health tech solutions. Key achievements include the development of proprietary technology that significantly improves medication detection speed and accuracy. Sano's impact is evident in its potential to transform medication management, leading to better patient outcomes and more efficient healthcare systems.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Health Management
Technology
Analytics, AI
Tags
Healthtech
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
United States
When was Sano Informed Prescribing founded?
Sano Informed Prescribing was founded in 2015.
Where is Sano Informed Prescribing’s headquarters located?
Sano Informed Prescribing’s headquarters is located in Franklin, US.
When was Sano Informed Prescribing’s last funding round?
Sano Informed Prescribing’s most recent funding round was for $5.5M (USD) in August 2016.
How many employees does Sano Informed Prescribing have?
Sano Informed Prescribing has 30 employees as of Feb 5, 2024.
How much has Sano Informed Prescribing raised to-date?
As of July 05, 2023, Sano Informed Prescribing has raised a total of $5.5M (USD) since Aug 25, 2016.
Add Comparison
Total Raised to Date
$5.5M
USD
Last Update Aug 25, 2016
Last Deal Details
$5.5M
USD
Aug 25, 2016
Seed
Total Employees Over Time
30
As of Feb 2024
Sano Informed Prescribing Address
393 Nichol Mill Ln
suite 34
Franklin,
37067
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts